Thaddeus Cromwell Reeder,Mark Wade Moore,Douglas Alan Lorenz,David Keith Lyon
申请号：
US14170405
公开号：
US20140221321A1
申请日:
2014.01.31
申请国别(地区):
US
年份:
2014
代理人:
摘要：
In one embodiment, the present application discloses methods of treating diseases and disorders with sulfasalazine and pharmaceutical formulations of sulfasalazine where the bioavailability of the sulfasalazine is increased. In another embodiment, the present application also provides dosing regimens for treating neurodegenerative diseases and disorders with compositions comprising sulfasalazine.
